#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Quasispecies Theory and the Behavior of RNA Viruses


A large number of medically important viruses, including HIV, hepatitis C virus, and influenza, have RNA genomes. These viruses replicate with extremely high mutation rates and exhibit significant genetic diversity. This diversity allows a viral population to rapidly adapt to dynamic environments and evolve resistance to vaccines and antiviral drugs. For the last 30 years, quasispecies theory has provided a population-based framework for understanding RNA viral evolution. A quasispecies is a cloud of diverse variants that are genetically linked through mutation, interact cooperatively on a functional level, and collectively contribute to the characteristics of the population. Many predictions of quasispecies theory run counter to traditional views of microbial behavior and evolution and have profound implications for our understanding of viral disease. Here, we discuss basic principles of quasispecies theory and describe its relevance for our understanding of viral fitness, virulence, and antiviral therapeutic strategy.


Vyšlo v časopise: Quasispecies Theory and the Behavior of RNA Viruses. PLoS Pathog 6(7): e32767. doi:10.1371/journal.ppat.1001005
Kategorie: Review
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1001005

Souhrn

A large number of medically important viruses, including HIV, hepatitis C virus, and influenza, have RNA genomes. These viruses replicate with extremely high mutation rates and exhibit significant genetic diversity. This diversity allows a viral population to rapidly adapt to dynamic environments and evolve resistance to vaccines and antiviral drugs. For the last 30 years, quasispecies theory has provided a population-based framework for understanding RNA viral evolution. A quasispecies is a cloud of diverse variants that are genetically linked through mutation, interact cooperatively on a functional level, and collectively contribute to the characteristics of the population. Many predictions of quasispecies theory run counter to traditional views of microbial behavior and evolution and have profound implications for our understanding of viral disease. Here, we discuss basic principles of quasispecies theory and describe its relevance for our understanding of viral fitness, virulence, and antiviral therapeutic strategy.


Zdroje

1. DomingoE

BaranowskiE

Ruiz-JaraboCM

Martin-HernandezAM

SaizJC

1998 Quasispecies structure and persistence of RNA viruses. Emerg Infect Dis 4 521 527

2. DomingoE

MartinV

PeralesC

Grande-PerezA

Garcia-ArriazaJ

2006 Viruses as quasispecies: biological implications. Curr Top Microbiol Immunol 299 51 82

3. DuffyS

ShackeltonLA

HolmesEC

2008 Rates of evolutionary change in viruses: patterns and determinants. Nat Rev Genet 9 267 276

4. BeigelJH

FarrarJ

HanAM

HaydenFG

HyerR

2005 Avian influenza A (H5N1) infection in humans. N Engl J Med 353 1374 1385

5. DawoodFS

JainS

FinelliL

ShawMW

LindstromS

2009 Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360 2605 2615

6. RambautA

PosadaD

CrandallKA

HolmesEC

2004 The causes and consequences of HIV evolution. Nat Rev Genet 5 52 61

7. FieldsBN

KnipeDM

HowleyPM

2007 Fields' virology Philadelphia Wolters Kluwer Health/Lippincott Williams & Wilkins2 v. (xix, 3091, I-3086 p.)

8. GeisbertTW

JahrlingPB

2004 Exotic emerging viral diseases: progress and challenges. Nat Med 10 S110 121

9. GerrishPJ

Garcia-LermaJG

2003 Mutation rate and the efficacy of antimicrobial drug treatment. Lancet Infect Dis 3 28 32

10. HollandJ

SpindlerK

HorodyskiF

GrabauE

NicholS

1982 Rapid evolution of RNA genomes. Science 215 1577 1585

11. EigenM

1971 Selforganization of matter and the evolution of biological macromolecules. Naturwissenschaften 58 465 523

12. BiebricherCK

EigenM

2006 What is a quasispecies? Curr Top Microbiol Immunol 299 1 31

13. EigenM

1993 Viral quasispecies. Sci Am 269 42 49

14. DomingoE

SaboD

TaniguchiT

WeissmannC

1978 Nucleotide sequence heterogeneity of an RNA phage population. Cell 13 735 744

15. BatscheletE

DomingoE

WeissmannC

1976 The proportion of revertant and mutant phage in a growing population, as a function of mutation and growth rate. Gene 1 27 32

16. SteinhauerDA

HollandJJ

1987 Rapid evolution of RNA viruses. Annu Rev Microbiol 41 409 433

17. VignuzziM

StoneJK

AndinoR

2005 Ribavirin and lethal mutagenesis of poliovirus: molecular mechanisms, resistance and biological implications. Virus Res 107 173 181

18. WilkeCO

2005 Quasispecies theory in the context of population genetics. BMC Evol Biol 5 44

19. OrrHA

2009 Fitness and its role in evolutionary genetics. Nat Rev Genet 10 531 539

20. Quinones-MateuME

ArtsEJ

2006 Virus fitness: concept, quantification, and application to HIV population dynamics. Curr Top Microbiol Immunol 299 83 140

21. DomingoE

HollandJJ

1997 RNA virus mutations and fitness for survival. Annu Rev Microbiol 51 151 178

22. de la TorreJC

HollandJJ

1990 RNA virus quasispecies populations can suppress vastly superior mutant progeny. J Virol 64 6278 6281

23. AaskovJ

BuzacottK

ThuHM

LowryK

HolmesEC

2006 Long-term transmission of defective RNA viruses in humans and Aedes mosquitoes. Science 311 236 238

24. WilkeCO

WangJL

OfriaC

LenskiRE

AdamiC

2001 Evolution of digital organisms at high mutation rates leads to survival of the flattest. Nature 412 331 333

25. BurchCL

ChaoL

2000 Evolvability of an RNA virus is determined by its mutational neighbourhood. Nature 406 625 628

26. CodoñerFM

DarósJ-A

SoléRV

ElenaSF

2006 The fittest versus the flattest: experimental confirmation of the quasispecies effect with subviral pathogens. PLoS Pathog 2 e136 doi:10.1371/journal.ppat.0020136

27. SanjuanR

CuevasJM

FurioV

HolmesEC

MoyaA

2007 Selection for Robustness in Mutagenized RNA Viruses. PLoS Genet 3 e93 doi:10.1371/journal.pgen.0030093

28. QuerJ

HersheyCL

DomingoE

HollandJJ

NovellaIS

2001 Contingent neutrality in competing viral populations. J Virol 75 7315 7320

29. DraghiJA

ParsonsTL

WagnerGP

PlotkinJB

2010 Mutational robustness can facilitate adaptation. Nature 463 353 355

30. AriënKK

TroyerRM

GaliY

ColebundersRL

ArtsEJ

2005 Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time. AIDS 19 1555 1564

31. RichmanDD

2006 Antiviral drug resistance. Antiviral Res 71 117 121

32. RollandM

BranderC

NickleDC

HerbeckJT

GottliebGS

2007 HIV-1 over time: fitness loss or robustness gain? Nat Rev Microbiol 5 1 2

33. KoelleK

CobeyS

GrenfellB

PascualM

2006 Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans. Science 314 1898 1903

34. OverbaughJ

BanghamCR

2001 Selection forces and constraints on retroviral sequence variation. Science 292 1106 1109

35. SanjuánR

MoyaA

ElenaSF

2004 The distribution of fitness effects caused by single-nucleotide substitutions in an RNA virus. Proc Natl Acad Sci USA 101 8396 8401

36. ElenaSF

SanjuánR

2005 Adaptive value of high mutation rates of RNA viruses: separating causes from consequences. J Virol 79 11555 11558

37. HolmesEC

2003 Error thresholds and the constraints to RNA virus evolution. Trends Microbiol 11 543 546

38. BiebricherCK

EigenM

2005 The error threshold. Virus Res 107 117 127

39. EigenM

2002 Error catastrophe and antiviral strategy. Proc Natl Acad Sci USA 99 13374 13376

40. HollandJJ

DomingoE

de la TorreJC

SteinhauerDA

1990 Mutation frequencies at defined single codon sites in vesicular stomatitis virus and poliovirus can be increased only slightly by chemical mutagenesis. J Virol 64 3960 3962

41. LeeCH

GilbertsonDL

NovellaIS

HuertaR

DomingoE

1997 Negative effects of chemical mutagenesis on the adaptive behavior of vesicular stomatitis virus. J Virol 71 3636 3640

42. CrottyS

CameronCE

AndinoR

2001 RNA virus error catastrophe: direct molecular test by using ribavirin. Proc Natl Acad Sci U S A 98 6895 6900

43. CrottyS

MaagD

ArnoldJJ

ZhongW

LauJY

2000 The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. Nat Med 6 1375 1379

44. DomingoE

ParienteN

AiraksinenA

Gonzaĺez-LopezC

SierraS

2005 Foot-and-mouth disease virus evolution: exploring pathways towards virus extinction. Curr Top Microbiol Immunol 288 149 173

45. Grande-PerezA

Gomez-MarianoG

LowensteinPR

DomingoE

2005 Mutagenesis-induced, large fitness variations with an invariant arenavirus consensus genomic nucleotide sequence. J Virol 79 10451 10459

46. Grande-PerezA

LazaroE

LowensteinP

DomingoE

ManrubiaSC

2005 Suppression of viral infectivity through lethal defection. Proc Natl Acad Sci U S A 102 4448 4452

47. Grande-PerezA

SierraS

CastroMG

DomingoE

LowensteinPR

2002 Molecular indetermination in the transition to error catastrophe: systematic elimination of lymphocytic choriomeningitis virus through mutagenesis does not correlate linearly with large increases in mutant spectrum complexity. Proc Natl Acad Sci U S A 99 12938 12943

48. SierraS

DávilaM

LowensteinPR

DomingoE

2000 Response of foot-and-mouth disease virus to increased mutagenesis: influence of viral load and fitness in loss of infectivity. J Virol 74 8316 8323

49. MalimMH

2009 APOBEC proteins and intrinsic resistance to HIV-1 infection. Philos Trans R Soc Lond, B, Biol Sci 364 675 687

50. SheehyAM

GaddisNC

ChoiJD

MalimMH

2002 Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418 646 650

51. HarrisRS

BishopKN

SheehyAM

CraigHM

Petersen-MahrtSK

2003 DNA deamination mediates innate immunity to retroviral infection. Cell 113 803 809

52. MangeatB

TurelliP

CaronG

FriedliM

PerrinL

2003 Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424 99 103

53. ZhangH

YangB

PomerantzRJ

ZhangC

ArunachalamSC

2003 The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424 94 98

54. VartanianJP

MeyerhansA

SalaM

Wain-HobsonS

1994 G→A hypermutation of the human immunodeficiency virus type 1 genome: evidence for dCTP pool imbalance during reverse transcription. Proc Natl Acad Sci U S A 91 3092 3096

55. KiefferTL

KwonP

NettlesRE

HanY

RaySC

2005 G→A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo. J Virol 79 1975 1980

56. JaniniM

RogersM

BirxDR

McCutchanFE

2001 Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells. J Virol 75 7973 7986

57. HolmesRK

MalimMH

BishopKN

2007 APOBEC-mediated viral restriction: not simply editing? Trends Biochem Sci 32 118 128

58. AndersonJP

DaifukuR

LoebLA

2004 Viral error catastrophe by mutagenic nucleosides. Annu Rev Microbiol 58 183 205

59. SeversonWE

SchmaljohnCS

JavadianA

JonssonCB

2003 Ribavirin causes error catastrophe during Hantaan virus replication. J Virol 77 481 488

60. HofmannWP

HerrmannE

SarrazinC

ZeuzemS

2008 Ribavirin mode of action in chronic hepatitis C: from clinical use back to molecular mechanisms. Liver Int 28 1332 1343

61. Ruiz-JaraboCM

LyC

DomingoE

de la TorreJC

2003 Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV). Virology 308 37 47

62. McCormickJB

KingIJ

WebbPA

ScribnerCL

CravenRB

1986 Lassa fever. Effective therapy with ribavirin. N Engl J Med 314 20 26

63. LoebLA

EssigmannJM

KazaziF

ZhangJ

RoseKD

1999 Lethal mutagenesis of HIV with mutagenic nucleoside analogs. Proc Natl Acad Sci USA 96 1492 1497

64. LoebLA

MullinsJI

2000 Lethal mutagenesis of HIV by mutagenic ribonucleoside analogs. AIDS Res Hum Retroviruses 16 1 3

65. HarrisKS

BrabantW

StyrchakS

GallA

DaifukuR

2005 KP-1212/1461, a nucleoside designed for the treatment of HIV by viral mutagenesis. Antiviral Res 67 1 9

66. Gonzalez-LopezC

AriasA

ParienteN

Gomez-MarianoG

DomingoE

2004 Preextinction viral RNA can interfere with infectivity. J Virol 78 3319 3324

67. SpringmanR

KellerT

MolineuxI

BullJ

2009 Evolution at a High Imposed Mutation Rate: Adaptation Obscures the Load in Phage T7. Genetics

68. GiffordRJ

RheeS-Y

ErikssonN

LiuTF

KiuchiM

2008 Sequence editing by Apolipoprotein B RNA-editing catalytic component [corrected] and epidemiological surveillance of transmitted HIV-1 drug resistance. AIDS 22 717 725

69. PillaiSK

WongJK

BarbourJD

2008 Turning up the volume on mutational pressure: is more of a good thing always better? (A case study of HIV-1 Vif and APOBEC3). Retrovirology 5 26

70. MulderLCF

HarariA

SimonV

2008 Cytidine deamination induced HIV-1 drug resistance. Proc Natl Acad Sci USA 105 5501 5506

71. ParienteN

SierraS

AiraksinenA

2005 Action of mutagenic agents and antiviral inhibitors on foot-and-mouth disease virus. Virus Res 107 183 193

72. ParienteN

AiraksinenA

DomingoE

2003 Mutagenesis versus inhibition in the efficiency of extinction of foot-and-mouth disease virus. J Virol 77 7131 7138

73. ArnoldJJ

VignuzziM

StoneJK

AndinoR

CameronCE

2005 Remote site control of an active site fidelity checkpoint in a viral RNA-dependent RNA polymerase. J Biol Chem 280 25706 25716

74. PfeifferJK

KirkegaardK

2003 A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity. Proc Natl Acad Sci U S A 100 7289 7294

75. PfeifferJK

KirkegaardK

2005 Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice. PLoS Pathog 1 e11 doi:10.1371/journal.ppat.0010011

76. VignuzziM

StoneJK

ArnoldJJ

CameronCE

AndinoR

2006 Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 439 344 348

77. VignuzziM

WendtE

AndinoR

2008 Engineering attenuated virus vaccines by controlling replication fidelity. Nat Med 14 154 161

78. RacanielloVR

2006 One hundred years of poliovirus pathogenesis. Virology 344 9 16

79. RenRB

CostantiniF

GorgaczEJ

LeeJJ

RacanielloVR

1990 Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell 63 353 362

80. BushmanFD

HoffmannC

RonenK

MalaniN

MinkahN

2008 Massively parallel pyrosequencing in HIV research. Aids 22 1411 1415

81. ErikssonN

PachterL

MitsuyaY

RheeSY

WangC

2008 Viral population estimation using pyrosequencing. PLoS Comput Biol 4 e1000074 doi:10.1371/journal.pcbi.1000074

82. Margeridon-ThermetS

ShulmanNS

AhmedA

ShahriarR

LiuT

2009 Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients. J Infect Dis 199 1275 1285

83. MazurkiewiczP

TangCM

BooneC

HoldenDW

2006 Signature-tagged mutagenesis: barcoding mutants for genome-wide screens. Nat Rev Genet 7 929 939

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2010 Číslo 7
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#